Skip to main content
Equibles

Thrivent Financial for Lutherans

Position in FTRE — Fortrea Holdings Inc.

CIK 314984 Minneapolis, MN
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,096,873
+$965,871 QoQ
Shares Held
120,510
+0.4% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Thrivent Financial for Lutherans holds $496,588,000 across 51 Biotechnology names. FTRE ranks #23 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TWST
Twist Bioscience Corp
 1,433,503 $147,478,787
2 EXEL
Exelixis, Inc.
 1,620,743 $88,184,625
3 REGN
Regeneron Pharmaceuticals, Inc.
 131,457 $81,968,697
4 RPRX
Royalty Pharma plc
 740,772 $41,535,085
5 JAZZ
Jazz Pharmaceuticals plc
 80,500 $19,398,084
6 ARGX
Argenx SE
 12,688 $11,771,545
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 20,169 $10,018,546
8 VCEL
Vericel Corp
 170,272 $7,575,400

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,096,873 120,510
2026-03-31 $1,131,002 120,064
2025-12-31 $2,102,412 121,879
2025-09-30 $1,325,720 157,449
2025-06-30 $1,133,077 229,368
2025-03-31 $919,937 121,846
2024-12-31 $2,336,732 125,294
2024-09-30 $1,407,240 70,362
2024-06-30 $1,732,178 74,215
2024-03-31 $3,092,225 77,036
2023-12-31 $2,761,567 79,128
2023-09-30 $2,317,248 81,051